Literature DB >> 29653267

Emerging landscape of circular RNAs in lung cancer.

Wei Hu1, Zhuo-Yue Bi2, Zhen-Long Chen3, Cong Liu1, Lin-Lin Li1, Feng Zhang1, Qun Zhou1, Wei Zhu1, Yang-Yi-Yan Song1, Bo-Tao Zhan4, Qian Zhang5, Yong-Yi Bi1, Cheng-Cao Sun6, De-Jia Li7.   

Abstract

Lung cancer, the leading cause of cancer deaths worldwide, is characterized with malignant cell growth. Advances in next-generation sequencing has helped us further understand RNA and identify novel circular RNAs (circRNAs) that may be useful in the early diagnosis and treatment of lung cancer. Similar to other noncoding RNAs, circRNAs present diverse biological functions in normal and disease states, including various types of cancers. This review focuses mainly on the poorly understood functions of circRNA in lung cancer. This paper also summarizes the recent advances in circRNA biogenesis, analyzes the role of circRNAs in cancers, and discusses the potential mechanisms of circRNAs in lung cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Back-splicing; Biomarker; Circular RNA; Lung cancer; MicroRNA sponge

Mesh:

Substances:

Year:  2018        PMID: 29653267     DOI: 10.1016/j.canlet.2018.04.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  47 in total

1.  Circular RNA HIPK3 induces cell proliferation and inhibits apoptosis in non-small cell lung cancer through sponging miR-149.

Authors:  Huibin Lu; Xinwei Han; Jianzhuang Ren; Kewei Ren; Zongming Li; Zhanguo Sun
Journal:  Cancer Biol Ther       Date:  2019-10-10       Impact factor: 4.742

2.  Exosomal circPVT1 derived from lung cancer promotes the progression of lung cancer by targeting miR-124-3p/EZH2 axis and regulating macrophage polarization.

Authors:  Ying Liu; Lei Li; Xiang Song
Journal:  Cell Cycle       Date:  2022-01-13       Impact factor: 4.534

3.  Ideal prognostic model in lung squamous cell carcinoma.

Authors:  Tomonari Kinoshita
Journal:  Transl Lung Cancer Res       Date:  2020-06

4.  The Circular RNA circSKA3 Binds Integrin β1 to Induce Invadopodium Formation Enhancing Breast Cancer Invasion.

Authors:  William W Du; Weining Yang; Xiangmin Li; Ling Fang; Nan Wu; Feiya Li; Yu Chen; Qihan He; Elizabeth Liu; Zhenguo Yang; Faryal Mehwish Awan; Mingyao Liu; Burton B Yang
Journal:  Mol Ther       Date:  2020-03-10       Impact factor: 11.454

5.  circRACGAP1 promotes non-small cell lung cancer proliferation by regulating miR-144-5p/CDKL1 signaling pathway.

Authors:  Min Lu; Hui Xiong; Zhen-Kun Xia; Bin Liu; Fang Wu; Hai-Xia Zhang; Chun-Hong Hu; Ping Liu
Journal:  Cancer Gene Ther       Date:  2020-08-11       Impact factor: 5.987

6.  circ0101675 promotes malignant process via sponging miR-1278 and upregulating WNT3A/5A in non-small cell lung cancer.

Authors:  Wei Du; Jianpeng Hu; Rong Hu; Min Yang; Yun Peng; Zhiwei Zhang; Yuehua Li; Xiusheng He
Journal:  J Cancer       Date:  2021-05-17       Impact factor: 4.207

7.  An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation.

Authors:  Jian Ma; William W Du; Kaixuan Zeng; Nan Wu; Ling Fang; Juanjuan Lyu; Albert J Yee; Burton B Yang
Journal:  Mol Ther       Date:  2021-08-06       Impact factor: 12.910

8.  Next-generation sequencing to investigate circular RNA profiles in the peripheral blood of preterm neonates with bronchopulmonary dysplasia.

Authors:  Xiaonan Mao; Yan Guo; Jie Qiu; Li Zhao; Junjie Xu; Jiao Yin; Keyu Lu; Mingshun Zhang; Rui Cheng
Journal:  J Clin Lab Anal       Date:  2020-02-24       Impact factor: 2.352

9.  Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis.

Authors:  Yaxin Guo; Yuying Guo; Chen Chen; Dandan Fan; Xiaoke Wu; Luyang Zhao; Bo Shao; Zhenqiang Sun; Zhenyu Ji
Journal:  Mol Cancer       Date:  2021-06-25       Impact factor: 27.401

10.  CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis.

Authors:  Yanbo Wang; Fenghai Ren; Dawei Sun; Jing Liu; BenKun Liu; YunLong He; Sainan Pang; BoWen Shi; FuCheng Zhou; Lei Yao; YaoGuo Lang; ShiDong Xu; JunFeng Wang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.